The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues
Abstract
Detection of lymphatic endothelal cells (LECs) has been problematic because of the lack of specific markers. The homeobox transcription factor Prox1 is expressed in LECs of murine and avian embryos. We have studied expression of Prox1 in human tissues with immunofluorescence. In 19‐wk‐old human fetuses, Prox1 and vascular endothelial growth factor receptor‐3 (VEGFR‐3) are coexpressed in LECs of lymphatic trunks and lymphatic capillaries. Prox1 is located in the nucleus, and its expression is mutually exclusive with that of the blood vascular marker PAL‐E. Prox1 is a constitutive marker of LECs and is found in tissues of healthy adults and lymphedema patients. Blood vascular endothelial cells (BECs) of hemangiomas express CD31 and CD34, but not Prox1. A subset of these cells is positive for VEGFR‐3. Lymphatics in the periphery of hemangiomas express Prox1 and CD31, but not CD34. In lymphangiomas, LECs express Prox1, CD31, and VEGFR‐3, but rarely CD34. In the stroma, spindle‐shaped CD34‐positive cells are present. We show that Prox1 is a reliable marker for LECs in normal and pathologic human tissues, coexpressed with VEGFR‐3 and CD31. VEGFR‐3 and CD34 are less reliable markers for LECs and BECs, respectively, because exceptions from their normal expression patterns are found in pathologic tissues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepatocyte migration during liver development requires Prox1
Sosa-Pineda, B., Wigle, J. T., & Oliver, G. (2000) · Nature Genetics · doi:10.1038/76996 · Cited by 381
Cited by
Baekkevold, E. S., Roussigné, M., Yamanaka, T., Johansen, F.-E., Jahnsen, F. L., Amalric, F., Brandtzaeg, P., Erard, M., Haraldsen, G., & Girard, J.-P. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63631-0 · Cited by 474
Hirakawa, S., Hong, Y.-K., Harvey, N., Schacht, V., Matsuda, K., Libermann, T., & Detmar, M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63851-5 · Cited by 439
VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells
Salven, P., Mustjoki, S., Alitalo, R., Alitalo, K., & Rafii, S. (2003) · Blood · doi:10.1182/blood-2002-03-0755 · Cited by 377
Self-citationFocus on lymphangiogenesis in tumor metastasis
Achen, M. G., McColl, B. K., & Stacker, S. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.017 · Cited by 351
Development of Secondary Lymphoid Organs
Randall, T. D., Carragher, D. M., & Rangel-Moreno, J. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090257 · Cited by 339
Metadata
- Authors
- Wilting, J., Papoutsi, M., Christ, B., Nicolaides, K. H., von Kaisenberg, C. S., Borges, J., Stark, G. B., Alitalo, K., Tomarev, S. I., Niemeyer, C., & RöSsler, J.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2002-06-07
- Volume
- 16
- Issue
- 10
- Pages
- 1271-1273
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2125546204
- Cited by
- 226
- References
- 1
- FWCI
- 3.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. https://app.cochat.ai/papers/10.1096/fj.01-1010fje
- The paper
- Wilting, J., Papoutsi, M., Christ, B., Nicolaides, K. H., von Kaisenberg, C. S., Borges, J., Stark, G. B., Alitalo, K., Tomarev, S. I., Niemeyer, C., & RöSsler, J. (2002). The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. The FASEB Journal. https://doi.org/10.1096/fj.01-1010fje
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.